Quantcast

Breast cancer study suggests new treatment could slow aggressive tumors

By Samantha Kimmey
Friday, February 15, 2013 21:47 EDT
google plus icon
Breast cancer awareness ribbons. Image via AFP.
 
  • Print Friendly and PDF
  • Email this page

New research into cancer growth has pinpointed a mechanism that impacts the aggressiveness of breast cancer tumors, according to a Scripps Research Institute study published in the Journal of Clinical Investigation.

It’s an important finding because doctors often find it difficult to figure out if a particular tumor will become aggressive — a determination which can affect treatment.

Scientists have been able to use the research to impede the growth of cancer in mice and prolong life, and they hope to quickly begin trials in humans.

Luckily nicotinamide, a B-complex vitamin which is used to slow the growth, is already used to treat cholesterol and skin diseases — meaning that the approval process for clinical trials likely won’t be quite as difficult, according to the San Diego Union Tribune.

[Image via AFP]

 
 
 
 
By commenting, you agree to our terms of service
and to abide by our commenting policy.
 
Google+